R
REPL
Replimune Group
9.70
-0.76-7.27%After Hours: 9.82 +0.12 +1.23%19:34 07/24 EDT
OPEN/PREV CLOSE10.30/10.46
TODAY RANGE9.65-10.38
VOL3.27M
MARKET CAP814.27M
52 WEEK RANGE1.500-13.24
AVG VOL (3M)5.37M
% TURNOVER3.89%
TURNOVER--
P/E (TTM)-2.8674
% RANGE6.79%
EPS(TTM)-3.3828
P/E(FORWARD)-4.7549
P/B4.829
BVPS2.009
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP792.39M
SHARES OUTSTANDING83.95M
NEXT EARNINGS08/05-08/10
FREE FLOAT81.69M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Replimune's RP1 Drug Probably Works, But It's Not A Buy Yet
NASDAQ·3d ago
Replimune Group Reaches Analyst Target Price
Reuters·3d ago
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Seeking Alpha·4d ago
Tracking Baker Brothers Portfolio: Q1 2026 Update
NASDAQ·5d ago
Noteworthy Monday Option Activity: HUT, REPL, BE
TipRanks·5d ago
Replimune Group put volume heavy and directionally bearish
Benzinga·07/16 21:05
12 Health Care Stocks Moving In Thursday's After-Market Session
TipRanks·07/10 09:59
‘Blue Sky’ Ahead? J.P. Morgan Picks 2 Stocks to Buy for the Rest of 2026
TipRanks·07/08 16:35
Replimune Group put volume heavy and directionally bearish
Seeking Alpha·07/01 17:51
Four stock-moving events to watch as FDA revives AdComs
TipRanks·06/30 16:05
Midday Fly By: Patrick to combine with LCI, AeroVironment reports Q4 beat
Seeking Alpha·06/30 14:09
Replimune: Stock Buoyant On Third Try At RP1 Approval - FDA AdCom May Be Crucial
TipRanks·06/30 13:10
Video: AeroVironment jumps after Q4 earnings beat